Positives from Q2 Financials BIEL had a 'Loss from

New Post Public Reply Private Reply Replies (1) Message Board
swordfish
978
Positives from Q2 Financials

BIEL had a 'Loss from Operations' of $29k in Q2, a continued move towards solvency. Q1 had a $70k 'Loss from Operations'. For reference the complete year 2020 had a 'Loss from Operations' of $1.04 million and 2019 had a $1.33 million Loss.

Our COB Rick Staelin loaned BIEL another $153k in Q2. In his position as Chairman of the Board Rick knows everything going on at BIEL and feels comfortable loaning more to BIEL.

Keith Nalepka our VP of Sales continues to hold his 100 million shares. Another vote of confidence in BIEL.


The Sales numbers were not what we were hoping for but with only one OEM, KT, seriously promoting products not bad.

I had made some noise a few months ago that several red flags could signal that BIEL was not able to produce enough devices for all of its OEMs.

* Automotive and other manufacturing segments that use electronic components have had to cut back on production due to a shortage of Integrated Circuits.
https://www.cips.org/supply-management/news/2...-shortage/

* DonJoy & SAI, who were due for a rollout of their 'Powered By ActiPatch' products in Q1 2021 are both MIA. DonJoy has a half dozen online sites selling three 'Powered by ActiPatch' products but extensive searches for Walgreens stores with these products have turned up nothing.

SAI was supposed to launch 10 products in March per an SAI manager I spoke with. Five months later and nothing.

* I did a post on a new electronic part I noticed in the KT device, a J107 Channel Switch. This part was not in the ActiPatch and fairly expensive for a small electronic part at 28 cents each in lots of 10k. I speculated that KT might be setting up the Wave for added function. Now I feel that this was a substitute for a part that BIEL could not get due to the Covid caused Chip Shortage.

* Several posters have noticed that BIEL's 'Cost of Goods Sold' has risen sharply in Q1 2021 & Q2 2021. One logical explanation is that BIEL is paying more for the electronic components that make up its devices due to the Shortage.


The good news is that electronic component manufacturers are working hard to ramp up production and meet the demand. Once supply increases prices should come back down lowering COGS and device manufacturing capabilities should improve.

If BIEL can get DonJoy and SAI operating as well as KT profitability is certain.

And then there are the other segments of the business; International, RecoveryRx, Smart Insole. Our COB needs to write an overdue 'Shareholder Letter' advising investors of BIEL's progress.

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Faces Lawsuit: Investor Unrest Unfolds

Updated Category News Views 5

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 74

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 25

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 42

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Artprice Bridges Art and AI Across the Hispanic World

Updated Category News Views 11

A Monumental Launch with Deep Roots I've been around long enough to see all sorts of moves in the art world and the tech world. But what Artprice by Artmarket is pulling off here—it’s a doozy. Thierry Ehrmann’s “Diálogo entre un pensador y la IA” just went live in Spanish, and that’s not some paperback thrill ride. We’re talking about an 1,800-page piece of...

Continue Reading
Tulsa Hosts Gradient's Global Tech and Investment Event

Updated Category News Views 21

Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...

Continue Reading
SOPHiA GENETICS' Q3 2026: Revenue Growth & Challenges

Updated Category News Views 7

Unpacking SOPHiA GENETICS' Third Quarter Figures Let's cut through the jargon and get straight to the brass tacks. SOPHiA GENETICS (NASDAQ:SOPH) just posted their third quarter numbers for 2026, and it’s a mixed bag, my friends. Sure, they boasted a 25% bump in revenue, hitting $24.3 million, but the devil's in the details—net losses nudged up to $20.3 million, not...

Continue Reading
Marathon Petroleum's Massive Q3 2026 Profit Surge

Updated Category News Views 13

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Continue Reading
Newcomers, Veterans Elevate NYSE's Tokenization Efforts

Updated Category News Views 89

Breaking New Ground at the NYSE When the bell rings at the NYSE these days, it's not just marking the start of another trading session. It's the sound of change clanging its way onto Wall Street. On November 3, 2026, the NYSE threw its hat deeper into the tokenization ring, a game-changer perhaps. They've roped in some big guns—Securitize, tZERO, Broadridge Financial...

Continue Reading
Illumina's Role in Singapore's Precision Medicine Leap

Updated Category News Views 160

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Continue Reading

Top 5 Most Recently Viewed Articles

Rising Demand and Technological Advancements in Krill Meal Market

Updated Category News Views 226

Understanding the Expanding Krill Meal Market The krill meal market is undergoing remarkable growth, fueled by a shift in consumer preferences favoring clean-label food products and natural flavor enhancers. According to recent estimates, the market is poised to expand significantly, reaching an impressive valuation by the end of an upcoming decade. This growth can be...

Continue Reading
Tango Therapeutics Begins Dosing in Pivotal Cancer Trial

Updated Category News Views 224

Tango Therapeutics Begins Dosing in Pivotal Cancer Trial BOSTON — Tango Therapeutics, Inc. (NASDAQ: TNGX), a dynamic biotechnology company dedicated to revolutionizing cancer care, has achieved a pivotal milestone by dosing the first patient in its TNG456 Phase 1/2 trial aimed at patients with MTAP-deleted solid tumors, particularly glioblastoma (GBM). Known for its...

Continue Reading
Investors Invited to Explore Class Action against Rentokil Initial

Updated Category News Views 188

Investors Encouraged to Join Class Action Against Rentokil Initial Bronstein, Gewirtz & Grossman, LLC, a well-respected law firm known for its expertise in securities cases, is reaching out to investors of Rentokil Initial Plc. This communication centers around a class action lawsuit that has been filed on behalf of those affected by some significant events concerning the...

Continue Reading
Murphy USA's Dividend Boost: A Commitment to Shareholders

Updated Category News Views 78

Murphy USA's Dividend Boost Reflects Confidence in Growth Murphy USA Inc. (NYSE: MUSA), a well-known player in the gasoline and convenience store sector, has recently announced an increase in its quarterly cash dividend. The company's Board has declared a new dividend of $0.48 per share, which represents a notable 6.7% rise from the previous dividend. This increase...

Continue Reading
Cloudinary Enhances Digital Asset Management with New Features

Updated Category News Views 181

Cloudinary's Innovative Update to Digital Asset Management Today, Cloudinary, the leading image and video platform, revealed significant advancements in its API-first digital asset management (DAM) solution. These enhancements are designed to address the evolving needs of brands in managing their visual assets efficiently and effectively. With a focus on streamlining...

Continue Reading